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CMR Mapping Techniques for Myocardium at Risk
Next Step Into a Bright Future?*
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m“The future depends on what you do today.”
—Mahatma Gandhi (1)
In the setting of myocardial infarction (MI) rapid
reperfusion of acutely ischemic, but yet only revers-
ibly injured, myocardium has the potential for
salvaging viable myocytes. The assessment of myo-
cardial salvage is clinically important because signifi-
cant salvage is associated with improved short- and
long-term survival after infarction (2,3). Moreover,
noninvasive imaging methods that can delineate the
area at risk (AAR) and salvageable myocardium are
crucial in assessing the efficacy of therapeutic ap-
proaches, including reperfusion.
See page 596
In recent years, cardiac magnetic resonance
(CMR) has emerged as the clinically most feasible
and accurate noninvasive tool to quantify the AAR
and myocardial salvage (4,5). Numerous studies
have clearly demonstrated that myocardial salvage
assessment by CMR not only is reproducible (6),
but also sensitively identifies and accurately quan-
tifies myocardial salvage in excellent agreement
with histopathology (7,8), single-photon emission
computed tomography (9), and angiographic scores
of myocardial salvage (10).
Most of the clinical experience in visualizing the
myocardium at risk has been reported for short-TI
triple-inversion recovery prepared fast spin echo
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ions are thought to mark edematous myocardium,
hich reflects the entire AAR (including both
eversible and irreversible injury). The salvaged
AR remains noninfarcted as a result of successful
eperfusion.
The STIR technique usually provides images
ith diagnostic quality, allowing a clinically useful
nterpretation in most patients. T2-weighted im-
ges, however, may be hampered by poor image
uality and artifacts affecting data analysis and
nterpretation (4,11). Although T2-weighted imaging
echnology has improved substantially in recent years,
ome still believe that T2-weighted imaging for delin-
ating the AAR is a “risky business” (11). However, as
ogently reviewed by Friedrich et al. (12) in a recent
Forum in this journal, in light of our clinical experience
nd many other CMR centers worldwide, the T2-
eighted technique offers tremendous potential for a
etter understanding of myocardial injury, post-
evascularization pathophysiology, and quantifying the
uccess of acute reperfusion.
Despite this enthusiasm, there is general agree-
ent in the CMR community that CMR protocols
or edema detection still require further optimiza-
ion. Fortunately, better T2-weighted CMR meth-
ds are in development or being evaluated (13,14).
he potentially most promising stride for CMR
maging of the myocardium at risk is the direct
easurement of T2 relaxation times by T2 map-
ing (15). This method has the potential to improve
bjectivity of T2-weighted imaging and might be less
ependent on confounders affecting signal intensity
nd image quality. T1 mapping might also be useful
or assessing myocardium at risk, but, as with T2
apping, published data are scarce.
In this issue of iJACC, Ugander et al. (16) take anmportant step toward improving the validation and
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605utility of quantitative T1 and T2 mapping for
assessment of myocardial edema/AAR. CMR was
performed in a canine occlusion-reperfusion model
using clinically available T1 mapping (Modified
Look-Locker Inversion-recovery [MOLLI]) and
T2 mapping (T2-prepared steady-state free preces-
sion) sequences, and the results were compared with
pathological assessment of the AAR with micro-
spheres as an independent reference standard. An
excellent agreement and correlation between both
mapping methods and microsphere results was
observed.
This thoughtful work is very much appreciated
and needed as it represents: 1) the first experimental
validation of T1 and T2 mapping techniques with
an appropriate pathology reference of the AAR;
2) an important expansion of previous work by
including whole-heart volumetric measurements of
the AAR by CMR and microspheres; 3) an addi-
tional demonstration and confirmation that T1 and
T2 increases detect changes in the myocardium at
risk; and 4) the first study to show that in vivo
non–contrast T1 mapping by CMR can also accu-
rately quantify the AAR.
Indeed, a very interesting finding of the work by
Ugander et al. (16) is that not only myocardial T2,
which is known to be sensitive to changes in tissue
water content, but also myocardial T1 changes after
acute reperfused MI in ways that are consistent with
myocardial edema. This finding is in line with
earlier reports that also demonstrated a relation of
prolonged T1 relaxation times and increased myo-
cardial water content in ischemically injured myo-
cardium (17,18). Pre-contrast T1 mapping there-
fore represents a new method for imaging the AAR.
From a pathophysiological point of view, the
changes in T1 and T2 rely on similar pathophysi-
ological mechanisms associated with ischemia-
induced edema formation in the myocardium, with
similar strengths and limitations. However, T1-
and T2-weighted sequences are different from an
MR physics point of view with consequently differ-
ent artifacts and susceptibility to other markers of
reperfusion injury (e.g., microvascular obstruction,
intramyocardial hemorrhage) (19,20). Ugander et316657/. Accessed April 16, 2012. J Am Coll Cardiol 2techniques provide similar information with respect
to AAR, and could even be used interchangeably
for this purpose. Thus, future studies should ad-
dress which of these mapping techniques is prefer-
able for quantification of the myocardium at risk,
considering image quality, artifacts, reproducibility,
and acquisition time. Furthermore, additional stud-
ies are required to fully understand what role T1
mapping may play in visualizing myocardial edema,
AAR, and myocardial salvage.
What are the clinical consequences of this pivotal
work? Should we abandon STIR sequences from
our scanners in favor of quantitative T2 or T1
mapping? This is probably too early as we need
more human data for T2 mapping and even more
for T1 mapping, including clinical settings. These
data are necessary for the quantification of myocar-
dium at risk in acute MI, but also for other cardiac
diseases that are known to cause global or regional
edema (e.g., acute coronary syndromes, myocardi-
tis, stress cardiomyopathy) (4,21). However, the
new mapping sequences have the potential for a
more reliable detection of myocardial edema by
minimizing artifacts associated with conventional
T2-weighted imaging and preventing subjective
interpretation. Furthermore, T1 and T2 differences
between edematous and noninfarcted myocardium
may be more easily detected with hard cutoff values.
The take-home message of the study by Ugander
et al. (16) is that, although accurate CMR ap-
proaches for assessing the myocardium at risk are
already available, even more reliable, robust, and
now validated techniques are under way and may
soon be available. This further increases the lead of
CMR over other imaging modalities in character-
izing tissue pathology for diagnosis and therapy.
Surely, these mapping techniques have to be tested
in various clinical settings and larger cohorts before
broad clinical utilization, but studies like these pave
the way for a bright future of CMR assessment of
the myocardium at risk and myocardial salvage.
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